The rising cost of drugs and how to address it

Bruce Johnson, MD of the Dana-Farber Cancer Institute, Boston, MA and recently elected president of the American Society of Clinical Oncology (ASCO), discusses the increasing cost of drugs and how he plans to address the issue as the president of ASCO. He mentions one of the abstracts presented at the ASCO 2016 Annual Meeting, in Chicago, IL, which showed that the cost of drugs can vary more than 5-fold from one country to another. Prof Johnson further discusses new developments, in particular biosimilars.

Share this video